Wela Strategies Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$21.4M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$12.4M |
| 3 |
Deere & Co
DE
|
+$10.8M |
| 4 |
GE Vernova
GEV
|
+$10.2M |
| 5 |
Nike
NKE
|
+$9.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$31.5M |
| 2 |
Vanguard Total Bond Market
BND
|
+$12.2M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$7.14M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$5.46M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$5.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.27% |
| 2 | Consumer Discretionary | 7.94% |
| 3 | Industrials | 4.21% |
| 4 | Healthcare | 1.08% |
| 5 | Energy | 0.47% |
Similar funds
Wela Strategies's Q4 2024 Portfolio in Review
As of Q4 2024, Wela Strategies held 76 positions worth $232M, up 1.1% from $229M the previous quarter. Its ten largest holdings account for 77% of the portfolio.
Wela Strategies deployed $32.5M of net new capital in Q4 2024, opening 24 new positions and adding to 19 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 46,113 shares worth $451K.
By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 0.29% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $31.5M trimmed.
- Wela Strategies's largest Q4 2024 buy was Vertex Pharmaceuticals: 46,113 shares worth $451K.
- Wela Strategies added most to Deere & Co in Q4 2024, an estimated $10.8M increase.
- Wela Strategies's biggest Q4 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $31.5M.
- Wela Strategies fully exited Vanguard Total Bond Market in Q4 2024, selling an estimated $12.2M.
- Wela Strategies's ten largest holdings make up 77% of its $232M portfolio in Q4 2024.
- Wela Strategies opened 24 new positions and closed 23 in Q4 2024.
- Wela Strategies's portfolio value rose 1.1% quarter-over-quarter to $232M.
Based on Wela Strategies's 13F filing for Q4 2024, filed 13 Jan 2025.